Arbutus Biopharma Corporation (ABUS)
NASDAQ · Healthcare
Arbutus Biopharma Corporation Income Statement 2011–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenue | 14.1M | 6.2M | 18.1M | 39.0M | 11.0M | 6.9M | 6.0M | 5.9M | 10.7M | 1.5M | 23.3M | 15.0M | 15.5M | 14.1M | 16.8M |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profitability | |||||||||||||||
| Operating Income | -38.2M | -76.3M | -78.1M | -65.5M | -73.5M | -57.8M | -143.9M | -89.8M | -110.9M | -491.6M | -103.9M | -33.4M | -12.2M | -12.9M | -10.7M |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | -33.5M | -69.9M | -72.8M | -69.5M | -76.2M | -63.7M | -153.7M | -57.1M | -84.4M | -384.2M | -62.7M | -38.8M | -14.1M | 29.6M | -10.1M |
| Per Share Data | |||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 192M | 186M | 166M | 151M | 106M | 76M | 65M | 55M | 55M | 53M | 45M | 22M | 15M | 14M | 11M |
Arbutus Biopharma Corporation Income Statement — FAQ
Arbutus Biopharma Corporation (ABUS) income statement over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABUS's income statement history?
The chart and table above show Arbutus Biopharma Corporation's income statement by year and by quarter, including the growth rate.